Cargando…
Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
BACKGROUND: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been increasingly used over the last decade in patients with refractory cardiogenic shock. ECMO weaning can, however, be challenging and lead to circulatory failure and death. Recent data suggest a potential benefit of levos...
Autores principales: | Guilherme, Enrique, Jacquet-Lagrèze, Matthias, Pozzi, Matteo, Achana, Felix, Armoiry, Xavier, Fellahi, Jean-Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367381/ https://www.ncbi.nlm.nih.gov/pubmed/32677985 http://dx.doi.org/10.1186/s13054-020-03122-y |
Ejemplares similares
-
Correction to: Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020) -
Levosimendan for VA‐ECMO weaning: the silver lining
por: Kaddoura, Rasha, et al.
Publicado: (2021) -
Functional evaluation of sublingual microcirculation indicates successful weaning from VA-ECMO in cardiogenic shock
por: Akin, Sakir, et al.
Publicado: (2017) -
Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
por: Chen, Yu-Wen, et al.
Publicado: (2022) -
Should ECMO be used in cardiogenic shock?
por: Gokalp, Orhan, et al.
Publicado: (2019)